Ticker: AXSM

Company: Axsome Therapeutics, Inc.

Person: Mark Coleman, director

Transaction date: Nov. 19, 2024

Reporting date: Nov. 20, 2024

Average share price: 5.94

Bought 33410.0 shares for 198455.4